Introduction {#Sec1}
============

Fungi are biosynthetically talented organisms capable of producing a wide range of chemically diverse and biologically intriguing small molecules. *Phellinus igniarius*, belonging to Polyporaceae family, is widely distributed in Yunnan and Sichuan Provinces of China \[[@CR1]\]. It preferably grows on stems of aspen, robur, and birch. Its fruiting body was used to treat fester, abdominalgia, bloody gonorrhea and antidiarrheal in traditional Chinese medicine \[[@CR2]\]. Previous chemical investigations on both fruiting bodies and cultures of this fungus reported various secondary metabolites with interesting structures and significant bioactivities \[[@CR3]--[@CR7]\]. Phelligridins D and E showed selective cytotoxicity against a human lung cancer cell line (A 549) and a liver cancer cell line (Bel 7402) \[[@CR3]\], while phelligridins H--J, being pyrano\[4,3-c\] \[[@CR2]\] benzopyran-1,6-dione and furo\[3,2-c\]pyran-4-one derivatives, showed cytotoxic activity against human cancer cell lines and protein tyrosine phosphatase 1B inhibition \[[@CR4]\]. A pyrano\[4,3-c\] \[[@CR2]\] benzopyran-1,6-dione derivative and a novel 26-membered macrocyclic metabolite phelligridimer A with antioxidant activities were also isolated from the fruiting bodies \[[@CR5], [@CR6]\]. Moreover, several tremulane sesquiterpenes were obtained from the cultures of this fungus, some of which showed significant vascular-relaxing activities against phennylephrine-induced vasoconstriction \[[@CR7]\]. To seek for more active molecules, further investigation of this fungus has resulted in the isolation of two pregnene steroids (**1** and **2**) and three sesquiterpenes (**3**--**5**) (Fig. [1](#Fig1){ref-type="fig"}). Compounds **1** and **2** are unusual 4-methyl homopregnane derivatives \[[@CR8]\], and compound **5** is a rare spiroaxane sesquiterpene which was firstly isolated from the marine sponge *Axinella cannabina* in 1973 \[[@CR9]\]. Based on the results of previous biological assays \[[@CR10], [@CR11]\], compounds **1**, **2**, and **5** were tested for their cytotoxicity in vitro against five human tumor cell lines, while compounds **3** and **4** were tested for their vascular-activities against phenylephrine-induced vasoconstriction. This paper describes the isolation, structure elucidation and results of biological activities.Fig. 1Structures of compounds **1**--**5**

Results and Discussion {#Sec2}
======================

Compound **1** was isolated as a white amorphous powder. The HREIMS data (*m/z* 364.2611 \[M\]^+^) indicated the molecular formula C~22~H~36~O~4~, requiring five degrees of unsaturation. The IR absorption bands at 3441 and 1631 cm^−1^ suggested the presence of hydroxy and double bond groups, respectively. The ^1^H NMR spectrum of **1** (Table [1](#Tab1){ref-type="table"}) displayed signals of three methyls (*δ*~H~ 0.74, 0.94, and 1.18). The ^13^C NMR (Table [1](#Tab1){ref-type="table"}) and DEPT spectra of **1** indicated 22 carbon resonances, including an oxygenated methylene carbon (*δ*~C~ 66.3), two oxygenated methines (*δ*~C~ 72.3, 73.1), one oxygenated quaternary carbon (*δ*~C~ 86.4), and a tetrasubstituted double bond (*δ*~C~ 130.9 and 135.1). Apart from one double bond, the remaining four degrees of unsaturation indicated that **1** possessed a four-ring system. Inspection of ^1^H-^1^H COSY correlations resulted in the fragments as shown (Fig. [2](#Fig2){ref-type="fig"}). In the HMBC spectrum (Fig. [2](#Fig2){ref-type="fig"}), correlations from *δ*~H~ 3.73 (br s, H-3) to *δ*~C~ 26.7 (t, C-1), 30.5 (t, C-2) and 41.8 (d, C-5), *δ*~H~ 0.94 (3H, d, *J* = 6.0 Hz, Me-22) to *δ*~C~ 72.3 (d, C-3), 37.3 (d, C-4) and C-5, *δ*~H~ 3.86 (H, d, *J* = 10.7 Hz, H-19a) and 3.63 (H, d, *J* = 10.7 Hz, H-19) to C-1 and C-5 gave an evidence for a six-member ring A. Besides, correlations of *δ*~H~ 1.69 (H, overlap, H-6a) and *δ*~H~ 2.10 (H, m, H-7a) with *δ*~C~ 130.9 (s, C-8), H-19 with *δ*~C~ 135.1 (s, C-9) and *δ*~C~ 41.7 (s, C-10) indicated the fragments of C-6-C-7-C-8, C-9-C10. Moreover, C-8 and C-9 were connected by the double bond. Hence, another six-member ring B was established. Likewise, in the HMBC spectrum, the correlations from *δ*~H~ 0.74 (3H, s, Me-18) to *δ*~C~ 30.4 (t, C-12) and 48.7 (d, C-14), from H-7 to C-14 and from *δ*~H~ 2.28 (2H, m, H-11) to C-9 indicated the presence of ring C. The last ring D was clearly established by HMBC correlations of Me-18 and *δ*~H~ 1.75 (H, overlap, H-16b) with *δ*~C~ 86.4 (s, C-17). Finally, the backbone of a 6/6/6/5 ring system related to that of 3,17,20-trihydroxy-4-methylpregn-8-en-7-one \[[@CR7]\] was deduced. In the ROESY spectrum (Fig. [2](#Fig2){ref-type="fig"}), correlations between H-22/H-5 and H-3/H-4 were observed, suggesting that H-3 and H-4 were both *β* oriented. Thus, the structure of compound **1** was elucidated to be 3*α*,17*α*,19,20-tetrahydroxy-4*α*-methylpregn-8-ene, as shown.Table 1^1^H and ^13^C NMR data for **1** and **2** (*δ* in ppm, *J* in Hz)No.12^1^H^13^C^1^H^13^C11.92, m26.7, CH~2~1.61, overlap32.1, CH~2~1.50, m1.48, m21.52, m30.5, CH~2~1.76, m30.5, CH~2~1.80, m1.71, m33.73, br s72.3, CH3.69, brd (2.5)72.4, CH41.60, overlap37.3, CH1.54, m36.8, CH51.59, overlap41.8, CH1.59, overlap41.7, CH61.69, overlap21.7, CH~2~1.73, m21.9, CH~2~1.35, m1.30, m72.10, m28.1, CH~2~2.11, overlap28.4, CH~2~2.04, m2.04, m8130.9, C129.0, C9135.1, C133.9, C1041.7, C37.5, C112.23, m25.7, CH~2~2.33, dt (19.0,4.0)33.4, CH~2~2.09, overlap121.80, m30.4, CH~2~4.17, d (4.0)73.4, CH1.70, overlap1346.7, C49.9, C142.80,m48.7, CH3.23,m41.6, CH151.74, overlap24.0, CH~2~1.83, m22.9, CH~2~1.40, m1.46, m162.13, m38.9, CH~2~2.07, overlap38.5, CH~2~1.75, overlap1.79, m1786.4, C88.6, C180.74, s14.6, CH~3~0.63, s14.4, CH~3~193.86, d (10.7)66.3, CH~2~0.96, s18.5, CH~3~3.63, d (10.7)203.78, q (6.4)73.1, CH3.76, q (6.4)72.6, CH211.18, d (6.4)18.8, CH~3~1.29, d (6.4)18.4, CH~3~220.94, d (6.0)17.1, CH~3~0.95, d (6.5)16.7, CH~3~Data (*δ*) were measured in methanol-*d*~4~. The assignments were based on DEPT, ^1^H-^1^H COSY, HSQC, and HMBC experimentsFig. 2Key^1^H-^1^H COSY, HMBC and ROESY correlations of compound **1**

Compound **2**, also purified as a white amorphous powder, had the same molecular formula of C~22~H~36~O~4~ as that of compound **1**, according to its HREIMS at *m/z* 364.2605 (\[M\]^+^). The ^13^C NMR (Table [1](#Tab1){ref-type="table"}) spectroscopic data were similar to those of compound **1**. The main differences were the missing of an oxygenated methylene and the presence of an oxygenated methine in **2**, which revealed the change of substitution of a hydroxy group. It was further confirmed by the HMBC correlations of *δ*~H~ 0.63 (3H, s, Me-18) with the oxygenated methine carbon. The mentioned information suggested that the hydroxy group was located at C-12. On the basis of the ROESY experiment, H-12 was elucidated to be *β* oriented by correlations of H-12 with H-18. Therefore, compound **2** was established to be 3*α*,12*α*,17*α*,20-tetrahydroxy-4*α*-methylpregn-8-ene, as shown.

Compound **3**, a colorless oil, had a molecular formula of C~15~H~26~O~2~ on the basis of HREIMS at *m/z* 238.1931 (\[M\]^+^). The ^13^C NMR (Table [2](#Tab2){ref-type="table"}) and DEPT spectra of **3** indicated 15 carbon resonances, including three methyls, five methylenes (one oxygenated at *δ*~C~ 67.1), five methines (one *sp*^2^ carbon at *δ*~C~ 123.3), and two quaternary carbon (one oxygenated at *δ*~C~ 72.9 and one *sp*^2^ carbon at *δ*~C~ 136.0). Detailed analysis of NMR data suggested that compound **3** should be a cadinane-type sesquiterpene with a similar structure to that of 15-hydroxy-*α*-cadinol \[[@CR12]\]. The main difference between the two compounds was that the hydroxy should be placed at C-12 in **3** rather than at C-15 in 15-hydroxy-*α*-cadinol, which was confirmed by the correlations of *δ*~H~ 2.15 (H, m, H-11) and 0.78 (3H, d, *J* = 7.0 Hz, Me-13) with *δ*~C~ 67.1 (t, C-12) in the HMBC spectrum. Further 2D NMR data supported that the other parts of the structure of **3** were the same as those of 15-hydroxy-*α*-cadinol \[[@CR12]\]. Therefore, compound **3** was deduced to be 12-hydroxy-*α*-cadinol.Table 2^1^H NMR and ^13^C NMR data for compounds **3--5** (*δ* in ppm, *J* in Hz)No.345^1^H^13^C^1^H^13^C^1^H^13^C11.23, overlap51.0, CH1.67, dt (14.0, 2.0)46.3, CH57.8, C22.06, m23.9, CH~2~1.89, dd (11.5, 6.8)31.8, CH~2~2.45, dd (13.9, 7.8)42.8, CH~2~1.22, overlap1.56, overlap1.56, overlap31,94 \~ 2.01, m32.0, CH~2~4.04, t (8.2)72.1, CH4.58, t (6.7)78.2, CH4136.0, C138.0, C144.9, C55.50, s123.3 CH5.76, d (5.8)129.6, CH5.48, s130.7, CH61.79, m40.5, C2.44, m35.8, CH3.33, overlap76.3, CH71.33, m43.0, CH1.50, m43.9, CH1.03, m46.9, CH81.49, overlap23.2, CH~2~1.43, overlap23.0, CH~2~1.65, overlap25.2, CH~2~1.21, overlap1.43, overlap1.36, m91.74, dt (13.0, 3.8)42.7, CH~2~1.54, overlap35.7, CH~2~1.56, overlap33.1, CH~2~1.47, overlap1.44, overlap1.23, m1072.9, C72.5, C1.66, overlap32.6, CH112.15, m35.4, CH1.94, m37.3, CH1.55, overlap30.2, CH123,39 \~ 3.46, m67.1, CH~2~3.74, dd (10.7, 4.7)65.2, CH~2~0.89, d (6.7)21.5, CH~3~3.31, overlap130.78, d (7.0)10.6, CH~3~0.98, d (6.9)16.3, CH~3~0.87, d (6.7)21.1, CH~3~141.07, s20.5, CH~3~1.18, s29.3, CH~3~0.80, d (6.8)17.8, CH~3~151.66, s24.0, CH~3~1.74, s19.8, CH~3~1.75, s14.0, CH~3~Data (*δ*) were measured in methanol-*d*~4~. The assignments were based on DEPT, ^1^H-^1^H COSY, HSQC, and HMBC experiments

Compound **4**, a white amorphous powder, possessed the molecular formula C~15~H~26~O~3~, on the basis of its HREIMS at m/z 254.1904 (\[M\]^+^), 16 mass units higher than that of **3**. The 1D NMR spectroscopic data (Table [2](#Tab2){ref-type="table"}) were quite similar to those of **3**, with the main difference being an oxygenated methane replacing methylene signal confirmed by the HMBC correlations of *δ*~H~ 4.04 (H, t, *J* = 8.2 Hz, H-3) with *δ*~C~ 138.0 (s, C-4) and 129.6 (d, C-5). In the ROESY spectrum, the presence of correlations of H-1/H-3, H-1/H-6 indicated that H-1, H-3 and H-6 were at the same face assigned as *β* orientation. The correlations of H-6 with H-12 suggested that H-7 was at *α* orientation. In addition, the correlations of H-1 with H-9b, Me-14 with H-9a revealed that Me-14 was at *α* orientation. Hence, compound **4** was identified as 3*α*,12-dihydroxy-*δ*-cadinol, as shown.

Compound **5**, a colorless oil, had the molecular formula of C~15~H~26~O~2~ based on its HRESIMS at *m/z* 268.1814 (\[M + Na\]^+^), which implied the presence of three degrees of unsaturation. The IR spectrum showed absorption bands at 3440 and 1632 cm^−1^, indicating the presence of hydroxy and double bond groups, respectively. The ^13^C NMR (Table [2](#Tab2){ref-type="table"}) and DEPT spectra indicated 15 carbon resonances, classified as four methyls, three methlyenes, six methines (two oxygenated at *δ*~C~ 76.3 and 78.2; one *sp*^2^ carbon at *δ*~C~ 130.7), and two quaternary carbons (one *sp*^2^ carbon at *δ*~C~ 144.9; one *sp*^3^ quaternary carbon at *δ*~C~ 57.8). In consideration of one degree of unsaturation occupied by one double bond, compound **5** was revealed to possess a two-ring system. Analysis of the ^1^H-^1^H COSY spectrum resulted in the deduction of fragments of C-2-C-3, C-7-C-11 and C-6-C-7-C-8-C-9 as shown (Fig. [3](#Fig3){ref-type="fig"}). In the HMBC spectrum (Fig. [3](#Fig3){ref-type="fig"}), correlations from *δ*~H~ 0.87 (3H, d, *J* = 6.7 Hz, Me-13) to *δ*~C~ 78.2 (d, C-3), *δ*~H~ 2.45 (H, dd, *J* = 13.9, 7.8 Hz, H-2a) and 5.48 (H, s, H-5) to *δ*~C~ 57.8 (s, C-1) supported the foundation of a five-member ring A. Similarly, the other ring B was clearly shown by HMBC correlations of *δ*~H~ 3.33 (H, overlap, H-6), 1.56 (H, overlap, H-9a) and 0.89 (3H, d, *J* = 6.7 Hz, Me-12) with C-1, Me-12 with *δ*~C~ 33.1 (t, C-9). Hence, the two-ring system connected by the spirocarbon C-1 was deduced, which possessed the same skeleton as that of 15-hydroxy-6*α*,12-epoxy-7*β*,10*α*H,11*β*H-spiroax-4-ene \[[@CR13]\]. In the ROESY spectrum (Fig. [3](#Fig3){ref-type="fig"}), correlations of H-5/H~ax~-7 and H~ax~-7/H~eq~-6 revealed that H-6, H-7 were *β* oriented, while the correlations of H~eq~-6/H-2*β* and H-2*β*/H-3 suggested H-3 was also *β* oriented. However, the presence of correlation of H~ax~-10/H ~ax~-8*α* indicated H-10 was *α* oriented. Finally, compound **5** was established as 3*α*,6*α*-dihydroxy-spiroax-4-ene.Fig. 3Key^1^H-^1^H COSY, HMBC and ROESY correlations of compound **5**

Compounds **1**, **2**, and **5** were evaluated for their cytotoxicity against five human cancer cell lines. None was found to possess significant activity with IC~50~ values less than 40 μM. Compounds **3** and **4** were tested for the vascular-activities against phenylephrine-induced vasoconstriction. They exhibited the vascular-activities with the relaxing rates of 11.0 % and 7.0 % at 3 × 10^−4^ M, respectively. It's worth mentioning that this is the first time to report the vascular-activity of cadinane-type sesquiterpenes.

Experimental {#Sec3}
============

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotations were measured on a Jasco-P-1020 polarimeter. IR spectra were obtained using a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. NMR spectra were acquired with instrument of a Bruker Avance Ш 600 with deuterated solvent signals as internal standards. HREIMS were measured on a Waters Autospec Premier P776 spectrometer. HRESIMS were recorded on an API QSTAR Pulsar spectrometer. Silica gel (200--300 mesh and 80--100 mesh, Qingdao Marine Chemical Inc., China), Sephadex LH-20 and RP-18 gel (20--45 µM, Fuji Silysia Chemical Ltd., Japan) were used for column chromatography (CC). Preparative HPLC was performed on an Agilent 1100 series with a Zorbax SB-C18 (5 μM, 9.4 × 150 mm) column. Fractions were monitored by thin layer chromatography (TLC) (Qingdao Marine Chemical Inc., China) and spots were visualized by heating silica gel plates immersed in H~2~SO~4~ in EtOH, in combination with the Agilent 1200 series HPLC system (Eclipse XDB-C18 column, 5 μM, 4.6 × 150 mm).

Fungal Material and Cultivation Conditions {#Sec5}
------------------------------------------

Fruiting bodies of *Phellinus igniarius* were collected at Changbai Mountain National Nature Reserve, Antu, Jilin Province, China in 2008 and identified by Prof. Yu-Cheng Dai (Beijing Forestry University). A specimen (No. KIB20081017) was deposited at Kunming Institute of Botany, Chinese Academy of Sciences. The culture medium was composed of glucose (5 %), pork peptone (0.15 %), yeast powder (0.5 %), KH~2~PO~4~ (0.05 %) and MgSO~4~ (0.05 %). The initial PH was adjusted to 6.0 and the fermentation was carried out on a shaker at 150 rpm for 25 days.

Extraction and Isolation {#Sec6}
------------------------

The cultures (20 L) were filtered through cheesecloth to separate broth and mycelium. The broth was extracted four times with ethyl acetate, while the mycelium was extracted three times with CHCl~3~-MeOH (1:1). The organic layer of both parts were evaporated together to yield a crude extract (9 g). Then this residue was subjected on reverse-phased C18 column eluted with gradient mixture of MeOH and H~2~O (30:70--100:0, v/v). Fractions were collected and monitored by TLC. Similar fractions were pooled to give twelve sub-fractions (A--L). Sub-fraction L was isolated by reverse-phased C18 column eluted with mixture of MeOH and H~2~O (45:55, v/v), then purified by Sephadex LH-20 CC (Me~2~CO) to yield compound **1** (1.4 mg). Sub-fraction G was subjected to Sephadex LH-20 CC (MeOH) and silica gel CC eluted with a petroleum ether-acetone gradient system (6:1, v/v) to give compound **2** (0.8 mg). Sub-fraction I was separated by repeated CC on silica gel and purified by preparative HPLC (MeCN/H~2~O, from 0:100 to 40:60, 10 mL/min, 40 min) to obtain compound **3** (1.8 mg). Sub-fraction A, isolated by Sephadex LH-20 CC (MeOH) and reverse-phased C18 column eluted with mixture of MeOH and H~2~O (30:70, v/v) to yield compound **4** (0.7 mg). Sub-fraction J was subjected to silica gel CC eluted with a petroleum ether-acetone gradient system (4:1, v/v) and Sephadex LH-20 CC (Me~2~CO) to yield compound **5** (1.4 mg).

3*α*,17*α*,19,20-Tetrahydroxy-4*α*-methylpregn-8-ene (**1**): amorphous powder, ${\lbrack\mathit{\alpha}\rbrack}_{D}^{21.6}$ −7.2 (*c* 0.13 MeOH); IR (KBr) ν~max~ 3441, 2922, 2852, 1631, 1465, 1384, 1105, 1036 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (methanol-*d*~4~), see Table [1](#Tab1){ref-type="table"}; HREIMS: *m/z* 364.2611 (calcd for C~22~H~36~O~4~, \[M\]^+^, 364.2614).

3*α*,12*α*,17α,20-Tetrahydroxy-4*α*-methylpregn-8-ene (**2**): amorphous powder, ${\lbrack\mathit{\alpha}\rbrack}_{\text{D}}^{21.2}$ −9.7 (*c* 0.07 MeOH); IR (KBr) ν~max~ 3443, 2927, 1634, 1457, 1381, 1065 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (methanol-*d*~4~), see Table [1](#Tab1){ref-type="table"}; HREIMS: *m/z* 364.2605 (calcd for C~22~H~36~O~4~, \[M\]^+^, 364.2614).

12-Hydroxy-*α*-cadinol (**3**): colorless oil, ${\lbrack\mathit{\alpha}\rbrack}_{\text{D}}^{21.8}$ +18.7 (*c* 0.18 MeOH); IR (KBr) ν~max~ 3441, 2926, 1631, 1452, 1382, 1120, 1035 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (methanol-*d*~4~), see Table [2](#Tab2){ref-type="table"}; HREIMS: *m/z* 238.1931 (calcd for C~15~H~26~O~2~, \[M\]^+^, 238.1933).

3*α*,12-Dihydroxy-*δ*-cadinol (**4**): amorphous powder, ${\lbrack\mathit{\alpha}\rbrack}_{\text{D}}^{21.7}$ +9.6 (*c* 0.06 MeOH); IR (KBr) ν~max~ 3424, 2929, 1631, 1436, 1384, 1030 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (methanol-*d*~4~), see Table [2](#Tab2){ref-type="table"}; HREIMS: *m/z* 254.1904 (calcd for C~15~H~26~O~3~, \[M\]^+^, 254.1882).

3*α*,6*α*-Dihydroxy-spiroax-4-ene (**5**): colorless oil, ${\lbrack\mathit{\alpha}\rbrack}_{\text{D}}^{21.1}$ −4.2 (*c* 0.14 MeOH); IR (KBr) ν~max~ 3440, 2926, 2870, 1632, 1459, 1384, 1060 cm^−1^; for ^1^H (600 MHz) and ^13^C NMR (150 MHz) data (methanol-*d*~4~), see Table [2](#Tab2){ref-type="table"}; HRESIMS: *m/z* 268.1814 (calcd for C~15~H~26~O~2~Na, \[M + Na\]^+^, 268.1831).

Cytotoxicity Assay {#Sec7}
------------------

Human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549 cells, breast cancer MCF-7 and colon cancer SW480 cell lines were used in the cytoxic assay. All cell lines were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10 % fetal bovine serum (Hyclone, USA) in 5 % CO~2~ at 37 °C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates \[[@CR14]\].

Vasodilating Activity Assays {#Sec8}
----------------------------

Sprague--Dawley rats, weighing 250--350 g, were anaesthetized with pentobarbital sodium (40 mg/kg, i.p.), and the thoracic aorta was removed and placed in Krebs--Henseleit solution (KHS). An aortic ring of about 2--3 mm in length was suspended between two stainless steel hooks in a 5 mL water-jacketed bath containing KHS of the following composition (in mmol/L): NaCl, 120; KCl, 4.7; MgSO~4~·7H~2~O, 1.2; KH~2~PO~4~, 1.2; CaCl~2~·2H~2~O, 2.5; NaHCO~3~, 25; and glucose, 10. The bathing solution was maintained at 37 ± 0.5 °C and was bubbled with 95 % O~2~ and 5 % CO~2~ (pH 7.4) throughout the experiments. One of stainless steel hooks was then connected to a force--displacement transducer (Chengdu instrument factory, Sichuan, China). The initial tension was adjusted to 1.5 g and an equilibration period of 90 min was allowed before commencing the experiments. The resting tension acting in the artery was readjusted periodically until stabilization was achieved. After equilibration, the reactivity of the thoracic aorta was ensured by KCl (60 mmol/L)-induced contraction. When a steady contraction was reached, 10^−5 ^mol/L Acetylcholine (ACh) was added to induce endothelium-dependent relaxation. This step was necessary to verify the integrity of the endothelium.

In order to investigate the effects of various agents on phenylephrine hydrochloride (PE)-induced contraction, when a steady contraction induced by PE (10^−6 ^mol/L) was reached, various agents (3 × 10^−4^ mol/L) was added to the organ bath. The resulting relaxation was expressed as a percentage (%) of the PE-induced steady contraction in the absence of treatment with various agents.
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